For patients with symptomatic aortic regurgitation at high surgical risk, a transcatheter aortic valve replacement system ...

The Heart Valve Devices Market is valued at USD 12.18 Billion in 2024 and is expected to reach USD 41.88 Billion by 2035 at a ...

[18] The JenaValve™ (JenaValve Technology, Germany), the Lotus™ Valve (Sadra Medical, Inc., CA, USA) and the AorTx™ system (AorTx, Inc., CA, USA) have also been investigated in a limited ...

Join us for lunch today at hashtag #STS2025 in Meeting Room 150 at 11:55 AM. Discover the compelling clinical evidence behind the FDA HDE approval of AMDS Hybrid Prothesis for Acute Type I DeBakey ...